title: Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2.
authors.affiliation: Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York.
authors.forename: J A
authors.initials: JA
authors.lastname: Sparano
authors.forename: L J
authors.initials: LJ
authors.lastname: Brandt
authors.forename: J P
authors.initials: JP
authors.lastname: Dutcher
authors.forename: J S
authors.initials: JS
authors.lastname: DuBois
authors.forename: M B
authors.initials: MB
authors.lastname: Atkins
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D003424:Crohn Disease / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D007376:Interleukin-2